RESUMEN
@#<p style="text-align: justify;">Primary sinonasal ameloblastoma is an extremely rare odontogenic epithelial tumor histomorphologically identical to its gnathic counterparts but with distinct epidemiologic and clinicopathologic characteristics. We present a case of a 46-year-old female with a one year history of recurrent epistaxis, nasal obstruction and frontonasal headache. Clinical examination, CT scan and subsequent surgical excsion revealed an intranasal mass attached to the lateral nasal cavity with histomorphologic features of ameloblastoma and was signed out as extragnathic soft tissue ameloblastoma of the sinonasal area. Extraosseous extragnathic primary sinonasal ameloblastoma are rare but do occur and should be distinguished from infrasellar craniopharyngiomas.</p>
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Ameloblastoma , Tumores Odontogénicos , Neoplasias por Tipo Histológico , Neoplasias , Epistaxis , Recurrencia , Diagnóstico por Imagen , Diagnóstico por Imagen , Técnicas y Procedimientos Diagnósticos , Tomógrafos Computarizados por Rayos XRESUMEN
Objective. Classic high-grade osteosarcoma is uncommon in preadolescents (less than or equal to 10 years of age). The possibilities of clinicopathologic differences from the typical adolescent osteosarcoma patient have been raised. We sought to compare the presentation, treatment and survival of this subgroup of patients with published rates in order to determine if there is a need to use a treatment regimen different from that for regular adolescent osteosarcoma patients. Methods. Records of the University of the Philippines-Musculoskeletal Tumor Unit (UP-MuST) over a 15-year period (1993-2008) were reviewed and data collected on patients 10 years and younger with biopsy-proven classic high-grade intramedullary osteosarcoma who underwent complete treatment by the Unit. Demographics and survival rates were then compared with published rates for preadolescent and regular adolescent osteosarcoma cases. Results. There were fourteen patients; (6M:8F; age: 4-10 years). The most common presentation was a painful mass in the distal femur (8); the tumors most commonly had osteoblastic histology (12). Treatment consisted of neoadjuvant chemotherapy, wide surgical excision through ablation (9) or limb-saving surgery (5), and postoperative chemotherapy. There was a good histologic response (over 90% tumor necrosis) in four patients. Seven patients are ANED (alive no evidence of disease) 25 to 186 months after diagnosis. Five-year survival estimate is 52%, compared to a dismal 5 to 10% 15 years ago. Conclusion. Clinicopathologic presentation, clinical course, and overall survival in this subgroup of patients are comparable with published results for both preadolescent and adolescent osteosarcoma patients. There is no need to alter the present treatment regimen for this group of young patients.
Asunto(s)
Humanos , Masculino , Femenino , Niño , Osteosarcoma , Terapéutica , Terapéutica , Neoplasias , Neoplasias por Tipo Histológico , Neoplasias de los Tejidos Conjuntivo y Blando , Neoplasias de Tejido Conjuntivo , Neoplasias de Tejido ÓseoRESUMEN
Three Dade-Behring Dimension AR Analyzers are presently in use in the Philippine General Hospital Department of Laboratories. One machine was acquired 2 years ago and two new ones were added recently. In order to determine whether the three machines would produce equivalent results 16 samples were selected for patients with hepatic and/or renal disorder. All 16 samples were tested for 16 different analytes. The results were subjected to tests for coefficient correlation, simple linear regression using slope and intercept and t-test for comparison. We concluded that for two assays (globulin and phosphorus), the values were sufficiently similar. For seven other assays (for total protein, albumin, sodium, potassium, chloride, calcium, and magnesium), the results were statistically significantly different, and for the remaining eight assays (total hiliruhin, direct bilirubin, AST, ALT, ALP, glucose, BUN, and creatinine), the values obtained were not ideal for drawing up conclusions about comparability. For the latter group of assays we plan to pool patient specimens of appropriate numbers and levels and repeat testing at some specified later date.